Treatment strategies for diabetic patients suffering from erectile dysfunction

被引:14
作者
Chen, Yun [2 ]
Dai, Yutian [2 ]
Wang, Run [1 ]
机构
[1] Univ Texas Med Sch Houston, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Urol, Nanjing 210008, Peoples R China
关键词
diabetes; erectile dysfunction; treatment;
D O I
10.1517/14656566.9.2.257
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Erectile dysfunction is a common complication of diabetes. Clinical practice has no treatment modality specifically designed for the difficult to treat diabetic erectile dysfunction due to the multifactorial and complex pathophysiology of development. PDE type 5 inhibitors are the first-line treatment option. Non-responders should have total and free testosterone checked and testosterone replacement is recommended for hypogonadal patients. For patients who cannot take PDE type 5 inhibitors, or are proven non-responders, the vacuum constriction device continues to serve as a major treatment option. Intracavernosal injection is the most effective medical therapy for diabetic erectile dysfunction despite its high dropout rate. Use of the Medicated Urethral System for Erection to overcome the disadvantages of needle injection is disappointing due to lack of effectiveness. Penile prosthesis will continue to play an important role in diabetic patients with severe erectile dysfunction in coming years.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 100 条
[1]
Improvement of erectile function in diabetic rats by insulin: Possible role of the insulin-like growth factor system [J].
Abdelbaky, TM ;
Brock, GB ;
Huynh, H .
ENDOCRINOLOGY, 1998, 139 (07) :3143-3147
[2]
Risk of infection with an antibiotic coated penile prosthesis at device replacement for mechanical failure [J].
Abouassaly, Robert ;
Angermeier, Kenneth W. ;
Montague, D. K. .
JOURNAL OF UROLOGY, 2006, 176 (06) :2471-2473
[3]
Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes [J].
Ahn, GJ ;
Yu, JY ;
Choi, SM ;
Kang, KK ;
Ahn, BO ;
Kwon, JW ;
Kang, SK ;
Lee, BC ;
Hwang, WS .
INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 (05) :260-266
[4]
The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats [J].
Ahn, GJ ;
Sohn, YS ;
Kang, KK ;
Ahn, BO ;
Kwon, JW ;
Kang, SK ;
Lee, BC ;
Hwang, WS .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (02) :134-141
[5]
Alexopoulou O, 2001, DIABETES METAB, V27, P329
[6]
ANAKA M, 2005, J UROLOGY, V173, P318
[7]
Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats [J].
Angulo, J ;
Cuevas, P ;
Gabancho, S ;
Gonzalez-Corrochano, R ;
Videla, S ;
de Tejada, IS .
JOURNAL OF SEXUAL MEDICINE, 2005, 2 (03) :341-346
[8]
Enhanced thromboxane receptor-mediated responses and impaired endothelium-dependent relaxation in human corpus cavernosum from diabetic impotent men:: Role of protein kinase C activity [J].
Angulo, Javier ;
Cuevas, Pedro ;
Fernandez, Argentina ;
Allona, Antonio ;
Moncada, Ignacio ;
Martin-Morales, Antonio ;
La Fuente, Jose Maria ;
de Tejada, Inigo Saenz .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02) :783-789
[9]
Nitric oxide and penile erection in streptozotocin-diabetic rats [J].
Ari, G ;
Vardi, Y ;
Finberg, JPM .
CLINICAL SCIENCE, 1999, 96 (04) :365-371
[10]
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study [J].
Aversa, A. ;
Greco, E. ;
Bruzziches, R. ;
Pili, M. ;
Rosano, G. ;
Spera, G. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (02) :200-207